Of vaccines
- Wants a diversified portfolio of vaccines
- Making sure to hedge bets
- WHO's Aylward looking at expanding manufacturing capacity of monoclonal antibodies for use against COVID-19
- In talks with Pfizer and Moderna on whether their products can be part of an early roll out of Covax vaccines at prices's 'appropriate' to populations
- 'Strong committment' from Pfizer CEO to make vaccine prices work for lower income countries.
